Membrane viability in the long-term peritoneal dialysis patient

Peritoneal Dialysis International

Volumn 17, Issue SUPPL. 3, 1997, Pages

  Schreiber Jr , Martin J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dialysate complications; Interstitium; Membrane failure; Mesothelium; Peritoneal membrane; Transport

Indexed keywords

DIALYSIS FLUID; GLUCOSE; GLYCOSAMINOGLYCAN;

ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CAPILLARY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG EFFECT; EPITHELIUM; FIBROSIS; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROCIRCULATION; PERITONEAL DIALYSIS; PERITONEUM; PHYSIOLOGY; RISK FACTOR; TRANSPORT AT THE CELLULAR LEVEL; TREATMENT OUTCOME; ULTRAFILTRATION; VASCULARIZATION;

BIOLOGICAL TRANSPORT; CAPILLARIES; DIALYSIS SOLUTIONS; EPITHELIUM; FIBROSIS; GLUCOSE; GLYCOSAMINOGLYCANS; HUMANS; MICROCIRCULATION; PATIENT ADMISSION; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; RISK FACTORS; TISSUE SURVIVAL; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0030634682     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701703s05     Document Type: Article

References (24)

1. Dobbie JW, Tasiaux N, Meijers P, et al. Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease. Br J Rheum 1994; 33:508-19.
2. Topley N. The cytokine network controlling peritoneal inflammation.Perit Dial Int 1995; 15(7)(Suppl):S35-40.
3. Hjelle JT, Miller-Hjelle MA, Bobbie JW. The biology of the mesothelium during peritoneal dialysis. Perit Dial Int 1995; 15(7)(Suppl):S13-23.
4. Flessner MF. The importance of the interstitium in peritoneal transport. Perit Dial Int 1996; 16(Suppl 1):S76-9.
5. Ronco C, Feriani M, Chiaramonte S, Brendolan A, Milan M, Le Greca G. Peritoneal blood flow: Does it matter? Perit Dial Int 1996; 16(Suppl 1):S70-5.
6. Agre P, Preston GM, Smith EL, et al. Aquaporin CHIP: The archetypal molecular water channel.Am J Physiol 1993; 265:F463-76.
7. Dobbie JW. Durability of the peritoneal membrane. Perit Dial Int 1995; 15(7)(Suppl):S87-92.
8. Williams JD. Biocompatibility in peritoneal dialysis Definitions and mechanisms. Perit Dial Int 1995; 15(7)(Suppl):S5-8.
9. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells (Review). Perit Dial Int 1994; 14(Suppl 3):S21-8.
10. Topley N. What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1995; 15(7)(Suppl):S101-8.
11. Di Paolo N, Garosi G, Biagioli M. Effects of dialysis fluid on cultured mesothelial cells. Perit Dial Int 1994; 14(Suppl 3):S12-15.
12. Marshall BC, Santana A, Xu QD, et al. Metalloproteinases and tissue inhibitor of metalloproteinase in mesothelial cells. J Clin Invest 1993; 91:1792-9.
13. Cannistra SA, Ottensmeier C, Tidy T, Defranso B. Vascular cell adhesions molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 1994; 22:996-1002.
14. Lin JJ, Parton L, Beveket G, Wadhwa NK. Plasminogen activator inhibitor-1 and peritoneal transport in diabetic and non-diabetic peritoneal dialysis patients. Clin Nephrol 1995; 44(5):310-15.
15. Gotloib L, Shostak A. Large mesothelial cells in peritoneal dialysis: A sign of degeneration of adaptation. Perit Dial Int 1996; 16:118-20.
16. Kumano K, Shimoda M, Hyodo T, Sakai T. The role of TGF-β in growth inhibition of peritoneal mesothelial cells in high-glucose dialysate. Pent Dial Int 1995; 15(7)(Suppl):S93-5.
17. Selgas R, Fernandez-Reys MJ, Basque E, et al. Functional longevity of the human peritoneum. How long is continuous peritoneal dialysis possible? Results of a prospective medium-long study. Am J Kidney Dis 1994; 1:23, 64-73.
18. Struijk DG, Krediet RT, Koomen GC, et al. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45:1739-44.
19. Lo WK, Brendolan A, Prowant BF, Moore HL, Khanna R, Twardowski ZJ. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 1994; 4:1466-74.
20. Heimbürger O, Waniewski AJ, Werynski A, et al. Peritoneal transport characteristics in CAPD patients with permanent loss of ultrafiltration.Kidney Int 1990; 38:495-506.
21. Pannekeet MA, Zemel D, Koomen, Struijk DG, Krediet RT. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995; 15:217-25.
22. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
23. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184-91.
24. Habatch G, Bloembergen WE, Mauger EA, Wolfe RA, Port FK. Hospitalization among United States dialysis patients: Hemodialysis versus peritoneal dialysis. J Am Soc Nephrol 1995; 5:1940-8.